Global Biomarkers Market – Regional Analysis
On the basis of region, the global biomarkers market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
Among regions, North America is expected to hold a dominant position in the global biomarkers market during the forecast period owing to increasing product designations by regulatory authorities. For instance, on September 1, 2022, U.S. FDA granted a breakthrough device designation to Roche’s Elecsys Amyloid Plasma panel, which is a blood based Alzheimer’s test. This panel helps healthcare professionals to detect Alzheimer’s at an early stage.
Biomarkers Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients